In this article
The Link Between HPV and Cervical Cancer
Data has proved that there is high cure rate for cervical cancer proton therapy. In daily life, I hear that cervical erosion will become cancerous when it is severe. In fact, not all of them will become cancerous. It can only be said that patients with cervical erosion are at risk for cervical cancer. Cervical erosion can be cured by active treatment Yes, it âs just that women often delay treatment, donât take this disease seriously, and eventually make more serious diseases appear. Misconceptions about cervical cancer are often the key points that lead to the onset of the disease. importance.
The occurrence of cervical cancer is closely related to a virus called human papilloma (HPV). Studies have shown that continuous infection with high-risk types of human papillomavirus is a necessary factor for the occurrence of cervical cancer and its precancerous lesions. The virus can be detected in most people with cervical cancer.
All women who have sex may be infected with the HPV virus through sexual contact. About 80% of women have been infected with the virus in their lifetime.
However, being infected with HPV does not necessarily lead to cervical cancer, because every healthy woman has some immunity in her body. Studies have confirmed that most womenâs immune systems can clear HPV that enters the body after being infected with HPV. Only a few women are unable to destroy the HPV entering the body, causing continuous HPV infection, which may cause cervical cancer. Some of these patients will progress to cervical cancer, a process that takes about 5 to 10 years.
Whether HPV progresses to cervical cancer is also related to the type of HPV. There are about 100 subtypes of HPV virus. The most common types of HPV in female reproductive tract infections are types 6, 11, 16, and 18, of which HPV6 and HPV11 are low-risk types, while HPV16 and 18 are high-risk types. Cervical cancer studies from countries around the world have found that HPV16 and HPV18 types have the highest infection rates among patients with cervical cancer.
Debunking the Myth of Cervical Erosion
Myth 2: Cervical erosion can turn into cancer
Many women have such a misunderstanding that they think cervical erosion can cause cervical cancer, and they are very afraid of cervical erosion.
Medically speaking, the columnar epithelium inside the cervical canal of a woman replaces the squamous epithelium of the cervix. When the doctor examines it, he finds that the local congestion of the cervix is ââred, which is called âcervical erosionâ. Erosion is not a ârotâ in the true sense. It can be a physiological phenomenon. Under the action of estrogen, women of childbearing age, the columnar epithelium inside the cervical canal is turned out, replacing the cervical squamous epithelium, and it appears âerosiveâ. And womenâs âerosionâ is rare before puberty and menopause due to relatively low estrogen levels in the body.
It is worth noting that cervical erosion can also be a common inflammatory condition. Early cervical cancer is very similar in appearance to cervical erosion and is easily confused. Therefore, if cervical erosion is found during gynecological examination, it cannot be taken lightly, and further cytology and biopsy are needed to confirm the diagnosis, rule out the possibility of cervical cancer, and treat it properly.
Misunderstanding 3: Gynecological examination is not valued
From the infection of HPV virus to the occurrence and development of cervical cancer, there is a gradual natural course, usually as long as 5 to 10 years. Therefore, as long as women are screened for cervical cancer on a regular basis, it is entirely possible to detect the âemergenceâ of the disease in time and kill it in the bud. At present, after treatment of patients with early-stage cervical cancer, the five-year survival rate can reach 85% to 90%.
Women of childbearing age must not neglect to perform annual gynecological examinations, including cervical cytology tests such as Pap smears or liquid-based cytology (TCT) tests, are important methods to detect cervical precancerous lesions and cervical cancer. In particular, the following populations at risk of cervical cancer should not be taken lightly:
Those who continue to be infected with high-risk types of HPV virus, that is, those who are positive for HPV16 and HPV18 when tested for HPV virus;
People with poor sexual behavior factors, including premature age of sexual life, multiple sexual partners, poor sexual health, etc., will increase the risk of cervical cancer;
Myth 4: âSmall Cluesâ Ignored
Cervical cancer may not cause any discomfort to patients at an early stage, and some symptoms are easily ignored. Women of childbearing age should learn to pay attention to the âhealth warningsâ issued by their bodies. Sometimes, although they are only âinformationâ, there may be hidden dangers.
After early detection, cervical cancer is not so terrible. Proton therapy is still hopefully curable. Proton therapy is actually accelerating positively charged protons through an accelerator to become very strong ionizing radiation. It enters the human body at a high speed and is guided by special-shaped equipment to eventually reach the tumor site. Because it is fast, the chance of interacting with normal tissues or cells in the body is extremely low. When it reaches a specific part of the tumor, the speed suddenly decreases And stop, release a lot of energy, this energy can kill cancer cells without causing damage to surrounding tissues and organs. Proton therapy can still effectively treat tumors while protecting these important organs or structural functions. This is in the conventional radiation It is impossible in treatment.
After women have a correct understanding of the disease, whether it is cervical erosion or cervical cancer, they must take a positive attitude to treat it. When there is cervical erosion, first eliminate the possibility of canceration, and then treat it properly. After treatment, it will be all right, and once you have cervical cancer, you will receive effective treatment at the first time, the condition will be controlled quickly, and your health will be less harmed.
For more information on proton therapy and appointments do call us at +91 96 1588 1588 or WhatsApp patient medical details on the same number. Patient can also send their medical reports to [email protected] for treatment plan.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination â travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

About Dr. Nishant Mittal
Dr. Nishant Mittal is a highly accomplished researcher with over 13 years of experience in the fields of cardiovascular biology and cancer research. Significant contributions to stem cell biology, developmental biology, and innovative research techniques mark his career. Research Highlights Dr. Mittal's research has focused on several key areas: 1) CardioâŠ
â Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.
